Persistent STAT3 Activation in Colon Cancer Is Associated with Enhanced Cell Proliferation and Tumor Growth

Cited by (433)

Items 301–400 of 433

1. Current overview of colitis-associated colorectal cancer
   Marta Sobczak, Marcin Wlazłowski, Hubert Zatorski, Maciej Sałaga, Jakub Fichna · 2014 · Open Life Sciences
2. Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo
   Xiaolei Zhang, Tao Lu, Yanhui Ma, Rui Li, Yingxin Pang, Hongluan Mao, Peishu Liu · 2020 · OncoTargets and Therapy
3. Investigation of molecular mechanisms underlying JAK/STAT signaling pathway in HPV-induced cervical carcinogenesis using ‘omics’ approach
   Kulbhushan Thakur, Divya Janjua, Gauri Shishodia, Arun Chhokar, Nikita Aggarwal, Joni Yadav, Tanya Tripathi, Apoorva Chaudhary, Anna Senrung, Alok Chandra Bharti · 2022 · Medical Oncology
4. Activation of pro-oncogenic pathways in colorectal hyperplastic polyps
   Catherine Do, Claudine Bertrand, Julien Palasse, Marie‐Bernadette Delisle, Elizabeth Cohen‐Jonathan Moyal, Catherine Seva · 2013 · BMC Cancer
5. MgcRacGAP inhibition stimulates JAK‐dependent STAT3 activity
   Arjan J. van Adrichem, Krister Wennerberg · 2015 · FEBS Letters
6. ANTITUMOR EFFICACY OF BOSWELLIA SERRATA EXTRACT IN MANAGEMENT OF COLON CANCER INDUCED IN EXPERIMENTAL ANIMAL
   Hanaa Hamdy Ahmed, Mona Abdel-Rahman, Fatma Elzahraa H. Salem, Aziza B. Shalby, Maha S. Lokman · 2013
7. STAT Activation in Malignancies: Roles in Tumor Progression and in the Generation of Antineoplastic Effects of IFNs
   Ben X. Wang, L. Platanias, E. Fish · 2013 · Journal of Interferon and Cytokine Research
8. Signaling pathways as therapeutic targets in biliary tract cancer
   Jennifer Yang, Matthew R. Farren, Daniel H. Ahn, Tanios Bekaii‐Saab, Gregory B. Lesinski · 2017 · Expert Opinion on Therapeutic Targets
9. Intestinal Epithelial Deletion of Sphk1 Prevents Colitis-Associated Cancer Development by Inhibition of Epithelial STAT3 Activation
   Seung Bin Park, Byung-il Choi, Beom Jae Lee, Nam Joo Kim, Yoon A Jeong, Moon Kyung Joo, Hyo Jung Kim, Jong‐Jae Park, Jae J. Kim, Yoon-Seok Noh et al. · 2019 · Digestive Diseases and Sciences
10. IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.
    Muhammad Babar Khawar, Maryam Mukhtar, Muddasir Hassan Abbasi, Nadeem Sheikh · 2017 · Europe PMC (PubMed Central)
11. The role of STAT3 in the colorectal cancer therapy
    Katarzyna Papierska, Violetta Krajka‐Kuźniak · 2020 · Journal of Medical Science
12. Hsa-miR-125b Therapeutic Role in Colon Cancer Is Dependent on the Mutation Status of the TP53 Gene
    Diana Cenariu, Alina‐Andreea Zimța, Raluca Andrada Munteanu, Anca Onaciu, Cristian Silviu Moldovan, Ancuta Maria Jurj, Lajos Ráduly, Alin Iulian Moldovan, Adrian Florea, Liviuţa Budişan et al. · 2021 · Pharmaceutics
13. Root Bark ofMorus Alba L.Induced p53-Independent Apoptosis in Human Colorectal Cancer Cells by Suppression of STAT3 Activity
    Hyun-Ji Park, Shin‐Hyung Park · 2021 · Nutrition and Cancer
14. Blockade of the SRC/STAT3/BCL-2 Signaling Axis Sustains the Cytotoxicity in Human Colorectal Cancer Cell Lines Induced by Dehydroxyhispolon Methyl Ether
    Ya-Chu Hsieh, Yuan‐Chang Dai, Kur‐Ta Cheng, Weiting Yang, Modukuri V. Ramani, Gottumukkala Venkata Subbaraju, Yi–Ju Chen, Chia‐Che Chang · 2023 · Biomedicines
15. Reduced expression of INK4a/ARF genes in stem-like sphere cells from rat sarcomas
    Hiromasa Fujii, Kanya Honoki, Toshifumi Tsujiuchi, Akira Kido, Kazuhiro Yoshitani, Toshio Mori, Yoshinori Takakura · 2007 · Biochemical and Biophysical Research Communications
16. A novel small molecular STAT3 inhibitor, 5Br-6b, induces apoptosis and inhibits migration in colorectal cancer cells
    Zhe Liu, Huan Wang, Lingnan Guan, Siyi Chen, Maode Lai · 2018 · Anti-Cancer Drugs
17. Control of Tyrosine Kinase Signalling by Small Adaptors in Colorectal Cancer
    Rudy Mevizou, Audrey Sirvent, Serge Roche · 2019 · Cancers
18. Structure-activity relationship analysis of mono-methylated quercetins by comprehensive MS/MS analysis and anti-proliferative efficacy in human colorectal cancer cells
    Sanghee Han, Yong Weon Yi, Hail Kim, Min Young Lee, Hyun Jin Choi, Yeon‐Sun Seong, In Jin Ha, Seok‐Geun Lee · 2025 · Biomedicine & Pharmacotherapy
19. SMAD7 Sustains XIAP Expression and Migration of Colorectal Carcinoma Cells
    Marco Colella, Andrea Iannucci, Claudia Maresca, F. Albano, Carmela Mazzoccoli, Federica Laudisi, Ivan Monteleone, Giovanni Monteleone · 2024 · Cancers
20. SIGIRR, a negative regulator of colon tumorigenesis
    Junjie Zhao, Jarod A. Zepp, Katarzyna Bulek, Xiaoxia Li · 2011 · Drug Discovery Today Disease Mechanisms
21. Interplay of transcription factors STAT3, STAT1 and AP-1 mediates activity of the matrix metallo-proteinase-1 promoter in colorectal carcinoma cells
    A. Müller, Josephine med. Gasch, Kai Frederik Albring, Fritz Aberger, Harini Nivarthi, M. Khemeri, Richard Moriggl, Karlheinz Friedrich · 2018 · Neoplasma
22. Synthetic derivatives of the natural product 13-amino 2-desoxy-4-epi-pulchellin inhibit STAT3 signaling and induce G2/M arrest and death of colon cancer cells
    Junxing Niu, Hui Huang, Fei Wang, Xianjing Zhang, Yi Liu, Qiang Yu, Lihong Hu · 2019 · Bioorganic & Medicinal Chemistry Letters
23. Survival of HT29 cancer cells is influenced by hepatocyte growth factor receptor inhibition through modulation of self-DNA-triggered TLR9-dependent autophagy response
    Bettina Bohusné Barta, Ágnes Simon, Lőrinc Nagy, Titanilla Dankó, Regina Eszter Raffay, Gábor Petővári, Viktória Zsiros, Anna Réka Sebestyén, Ferenc Sípos, Györgyi Műzes · 2022 · PLoS ONE
24. Oncogenic fingerprint of epidermal growth factor receptor pathway and emerging epidermal growth factor receptor blockade resistance in colorectal cancer
    Zain A. Sobani, Ashwin Shreekant Sawant, Mikram Jafri, Amit Keith Correa, İbrahim Halil Şahin · 2016 · World Journal of Clinical Oncology
25. Phospholipase Cγ1 links inflammation and tumorigenesis in colitis-associated cancer
    Kwang‐Il Park, Kwang-Youn Kim, Tae Woo Oh, Du‐Seock Kang, Eung‐Kyun Kim, Yong Ryoul Yang, Young‐Kyo Seo, Jin Yeul, Pann‐Ghill Suh · 2017 · Oncotarget
26. From bench to bedside: the past, present and future of IL-21 immunotherapy
    Austin M. Kim, Леи Жао, Tej R. Patel, Colin J. Bailey, Qian Bai, Mark R. Wakefield, Yujiang Fang · 2024 · Medical Oncology
27. Bioengineered Anthocyanin-Enriched Tomatoes: A Novel Approach to Colorectal Cancer Prevention
    Md Suzauddula, Kaori Kobayashi, Sunghun Park, Xiuzhi Susan Sun, Weiqun Wang · 2024 · Foods
28. Molecular mechanisms underlying TXNIP’s anti-tumor role in breast cancer, including interaction with a novel, pro-tumor partner: CAST
    Jasvinder Singh, Bindeshwar Sah, Yibin Deng, Robert C. Clarke, Liang Liu · 2025 · Cell Death and Disease
29. Non-cell-autonomous stimulation of stem cell proliferation following ablation of Tcf3
    Fei Yi, Bradley J. Merrill · 2009 · Experimental Cell Research
30. [Advances of the correlation between JAK-STAT3 signaling pathway and the biological behavior of non-small cell lung cancer].
    Yang Yu, Zhou Wang · 2010 · Europe PMC (PubMed Central)
31. Reduced expression of CYLD promotes cell survival and inflammation in gefitinib‐treated NSCLC PC‐9 cells: Targeting CYLD may be beneficial for acquired resistance to gefitinib therapy
    Yuan Yuan, Liu Liu, Yi Wang, Shangquan Liu · 2020 · Cell Biology International
32. Universal and Specific Functions of STAT3 in Solid Tumours
    Lidia Avalle, Gabriella Regis, Valeria Poli · 2012 · Springer eBooks
33. Identification of Thieno[3,2-d]pyrimidine derivatives as potent and selective Janus Kinase 1 inhibitors
    Younghoon Kim, Eunhye Jeon, Hyunwoo Ahn, Ju‐Hee Kang, Taebo Sim · 2025 · European Journal of Medicinal Chemistry
34. Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progression
    Madhurima Paul, Tamal Kanti Gope, Priyanka Das, Rupasri Ain · 2022 · BMC Cancer
35. The Role of Interleukin (IL)-6/IL-6 Receptor Axis in Cancer
    Manzoor Ahmad Mir, Masrat Bashir, Nusrat Jan · 2023 · Springer eBooks
36. Chondromodulin-1 functions as a tumor suppressor in gastric adenocarcinoma
    PENGFEI ZHANG, YING WANG, Po Xu, Shiyuan Song, Xiaojuan Zhu, Zhenguo Shi, Shegan Gao, Xiaoshan Feng · 2015 · International Journal of Oncology
37. Evaluation of the STAT3 inhibitor GLG‑302 for the prevention of estrogen receptor‑positive and ‑negative mammary cancers
    Robert H. Shoemaker, Jennifer T. Fox, M. Margaret Juliana, Fariba L. Moeinpour, Clinton J. Grubbs · 2019 · Oncology Reports
38. The Emerging Role of Janus Kinase Inhibitors in the Treatment of Cancer
    Dipanjan Karati, Kakasaheb Ramoo Mahadik, Piyush Trivedi, Dileep Kumar · 2022 · Current Cancer Drug Targets
39. Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: Role of cytokines
    Sajjad Khan · 2013
40. Cytokine Gene Polymorphisms in Colorectal Cancer
    Spaska Angelova Stanilova · 2012 · InTech eBooks
41. Cell–cell contacts induce STAT3 activity in colon carcinoma cells through an autocrine stimulation loop
    Svetlana A. Tsareva, Stefan Wagner, Annekatrin Müller, Florian Matthias Corvinus, Karlheinz Friedrich · 2010 · Journal of Cancer Research and Clinical Oncology
42. IL-6 Plays Crucial Roles in Sporadic Colorectal Cancer through the Cytokine Networks including CXCL7
    Takashi Uchiyama, Hirokazu Takahashi, Hiroki Endo, Eiji Sakai, Kunihiro Hosono, Yoji Nagashima, Atsushi Nakajima · 2012 · Journal of Cancer Therapy
43. Computer-aided prediction of inhibitors against STAT3 for managing COVID-19 associate cytokine storm
    Anjali Dhall, Sumeet Patiyal, Neelam Sharma, Naorem Leimarembi Devi, Gajendra P. S. Raghava · 2021 · Research Square
44. Novel Proteome Extraction Method Illustrates a Conserved Immunological Signature of MSI-H Colorectal Tumors
    Elez D. Vainer, Juliane Kania-Almog, Ghadeer Zatara, Yishai Levin, Gilad Wolf Vainer · 2020 · Molecular & Cellular Proteomics
45. A critical review of anticancer properties of Withania somnifera (L.) Dunal with respect to the biochemical mechanisms of its phytochemical constituents
    Rutwick Surya Ulhas, Poornananda Madhava Naik, U Vinayak, Praveen Nagella · 2021 · Plant Science Today
46. Association between the methylation of CpG islands in JAK-STAT pathway-related genes and colorectal cancer
    Jiesheng Rong, Rui Pu, Hongru Sun, Yupeng Liu, Tian Tian, Haoran Bi, Tingting Xia, Lei Zhang, Yuanyuan Zhang, Yashuang Zhao et al. · 2023 · Gene
47. Molecular pharmacology of multitarget cyclin-dependent kinase inhibitors in human colorectal carcinoma cells
    Sonal M. Manohar, Kalpana Sanjay Joshi · 2023 · Expert Opinion on Therapeutic Targets
48. Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer
    Yingjie Li, Dong-Xin Tang, Hongting Yan, Bing Yang, Zhu Yang, Feng-Xi Long · 2023 · World Journal of Clinical Cases
49. Role of CTLA4 and pSTAT3 Immunostaining in Colorectal Carcinoma Prognosis and Treatment
    Dina Mohamed Allam, Hend Ahmed Kasem, Amira H Hegazy, Shereen Fathy Mahmoud · 2024 · Iranian journal of pathology
50. Targeting STAT3 with SH-4-54 suppresses stemness and chemoresistance in cancer stem-like cells derived from colorectal cancer
    Xu-Fan Zhang, Qian Chen, Qin Li Jiang, Hu Q · 2024 · World Journal of Clinical Oncology
51. Preventive Effect of Helicobacter pylori Treatment on Colorectal Cancer Incidence and Mortality
    Yoon Suk Jung, Somin Jeon, Boyoung Park, Chang Mo Moon · 2026 · Journal of Gastroenterology and Hepatology
52. Chronic stress synergizes with Listeria monocytogenes to promote intestinal adenomagenesis via myeloid-derived suppressor cells
    Pingqian Qi, Lili Yin, Ruijia Wei, Siyuan Yang, Ziqing Liu, Ping Huang, Qiwen Yu, Su-Yi Xiong, Mengmeng Wang, Yan-Juan Deng et al. · 2025 · Frontiers in Immunology
53. Epigenetic Mechanisms of Colon Cancer Prevention: What Can Nutrition Do?
    Yuan‐Xiang Pan, Yukun Zhang, Hong Chen · 2014 · Springer eBooks
54. A Review of the Past, Present, and Future Directions of Neoplasia
    Alnawaz Rehemtulla, Brian Dale Ross · 2005 · Neoplasia
55. Targeting Signal Transducer and Activator of Transcription 3 for Colorectal Cancer Prevention and Treatment with Natural Products
    Baojin Hua, Weidong Li, Cihui Chen, Zheng Liu · 2016 · Cancer translational medicine
56. Intestinal Inflammation and Cancer of the Gastrointestinal Tract
    Markus Friedrich Neurath, Stefan Fichtner‐Feigl, Rebecca Kesselring · 2015 · Elsevier eBooks
57. Suppressor of activator protein-1 regulated by interferon expression in prostate cancer tissues and cells
    Shengwang Zhang, Pengfei Rong, Qian Chen, Wei Wang · 2019 · Life Sciences
58. A Brief Review on Dual Target of PARP1 and STAT3 for Cancer Therapy: A Novel Perception
    Kaviarasan Lakshmanan, Gowramma Byran, Manal Mohammed · 2020 · Current Enzyme Inhibition
59. Reduction in neutrophil elastase concentration by recombinant α1-antitrypsin (recAAT) does not alter bacterial loading in the sputum of cystic fibrosis patients
    John Edmund Moore, Adrienne Shaw, Beverley Cherie Millar, Lorraine Martin, Philip G. Murphy, Damian G. Downey, Madeleine Ennis, J.S. Elborn · 2004 · British Journal of Biomedical Science
60. The MicroRNA miR-223 Constrains Colitis-associated Tumorigenesis by Limiting Myeloid Cell Infiltration and Chemokine Expression
    Ciara L. Flynn, Gary E. Markey, Viola Neudecker, Charlotte Farrelly, Glenn T. Furuta, Holger K. Eltzschig, Joanne C. Masterson, Eóin N. McNamee · 2024 · The Journal of Immunology
61. Detrimental Impacts of High-Fat Diet on Colorectal Cancer Development: An Update on Molecular Mechanisms
    Bhuvaneswari Ponnusamy, Ponnulakshmi Rajagopal, Srinivasa Rao Sirasanagandla, Choy Ker Woon, Vishnu Priya Veeraraghavan, Selvaraj Jayaraman · 2025 · Current Nutrition & Food Science
62. The tumor promoter 12-O-tetradecanoylphorbol-13-acetate suppresses cell proliferation in metastatic melanoma through TC-PTP/PTPN2 and SH-PTP2/PTPN11
    Yuki Akamatsu, Mami Onishi, Taiki Nagano, Masahiro Oka, Shinji Kamada, Tetsushi Iwasaki · 2025 · The Journal of Biochemistry
63. The JAK/STAT Pathway in Cancer: From Molecular Mechanisms to Clinical Applications
    Yixing Liao, Qi Wei, Hongjun Song, Hao Zeng, Chang Qi, Yunchang Meng, Yuanyuan Zhang, Yuanyuan Zhang, Weimin Li, Yalun Li et al. · 2026 · MedComm – Oncology
64. Role of Prolactin and Its Receptor in Colorectal Cancer
    Naveen Kumar Neradugomma, Satheesh K. Sainathan, Joaquina Celebre Baranda, Dharmalingam Subramaniam, Shrikant Anant · 2014 · Current Colorectal Cancer Reports
65. Reconstructing transcriptional regulatory networks by probabilistic network component analysis
    Jinghua Gu, Jianhua Xuan, Xiao Wang, Ayesha N. Shajahan‐Haq, Leena A Hilakivi-Clarke, Robert C. Clarke · 2013 · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB)
66. Resistance to EGFR Targeting Treatments in Colorectal Cancer
    Michela Pucci, Mattia Lauriola · 2018 · Elsevier eBooks
67. Role of cGAS-STING signaling pathway in colon cancer
    Siwei Wang, Wen-Hao Su, Xuemei Jia, Haotian Jiang, Binglu Huang, Weiguo Dong · 2020 · World Chinese Journal of Digestology
68. Activation of STAT3 and its impacts on Proteasome Inhibitor-Induced Apoptosis in Laryngeal Sqaumous Carcinoma
    2017 · Cancer Studies and Therapeutics
69. Activation of STAT3 and its impacts on Proteasome Inhibitor-Induced Apoptosis in Laryngeal Sqaumous Carcinoma
    2017 · Cancer Studies and Therapeutics
70. Potential of Pre-Operative Serum Interleukin-6 as a Biomarker for Colorectal Cancers
    W. M. M. S. Bandara, Fathima T. Muhinudeen, S.L. Malaviarachchi, Anuradha Rathnayake · 2024 · Journal of cancer research updates
71. Regulation of translocator protein 18-kDa (Tspo) gene expression through a protein kinase C (PKC) epsilon signal transduction pathway
    Amani M. Batarseh · 2010 · DigitalGeorgetown (Georgetown University Library)
72. Inflammation and host-microbe signaling in the development and progression of colorectal carcinoma
    Yinghui Li · 2013 · Figshare
73. STAT1 and STAT3 Transcription Factors in Inflammation-associated Colon Cancer
    Paulina Rampetsreiter, Robert Eferl · 2012 · Springer eBooks
74. Molecular Targeting of Colorectal Cancer
    Mark L. Sundermeyer, Alfonso Bellacosa, Neal J. Meropol · 2007 · Humana Press eBooks
75. Th17 in sensitized human lymphocytes ex vivo ?
    J. Haefner, C. Krieg, I. Michel, Heike Weißer, Karlheinz Friedrich, Friedhelm Diel · 2009 · Inflammation Research
76. Neoplasia: Where We Have Been and Where We Are Going
    Alnawaz Rehemtulla · 2006 · Neoplasia
77. Neoplasia: An Anniversary of Progress
    Alnawaz Rehemtulla · 2007 · Neoplasia
78. The Role of SOCS3 Signaling in Ulcerative Colitis and Ulcerative Colitis-related Carcinogenesis
    Yi Li · 2012 · EUR Research Repository (Erasmus University Rotterdam)
79. Role of Prolactin and Prolactin Receptor Signaling in Colorectal Tumorigenesis
    Naveen Kumar Neradugomma · 2014 · KU ScholarWorks (University of Kansas)
80. The conservation of suppressor of Cytokine Signalling 3 in mediating intestinal homeostasis
    Emily Smith · 2016 · Lancaster EPrints (Lancaster University)
81. Identification and functional analysis of gene expression changes in acute myeloid leukaemia.
    Chung Hoow Kok · 2010 · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
82. Bone Marrow Dendritic Cells Tumor Exosomes Inhibit Differentiation of
    Huang‐Ge Zhang, Robert P. Kimberly, William E. Grizzle, Carla Isadora Falkson, Yuelong Liu, Liming Zhang, Chuanyu Li, Yingzi Cong, Shaohua Yu, Cunren Liu et al. · 2013
83. Transcription Factors and Colorectal Cancer: An Overview
    Uday Sankar Allam, Shilpa Kamatham, Maraline Adarsha, Sk. Md. Jasmine, P. V. Giri Prasad · 2017 · Springer eBooks
84. Functional Characterization of Protein Tyrosine Phosphatases in Tumorigenesis through Substrate Identification
    Peng Zhang · 2013 · OhioLink ETD Center (Ohio Library and Information Network)
85. Circulating biomarkers and prognosis in colorectal cancer
    Ashok R. Gunawardene · 2021 · Otago University Research Archive (University of Otago)
86. Inflammation suppresses DLG2 expression, preventing inflammasome formation
    Simon Keane, Matthew Herring, Peter Rolny, Yvonne Wettergren, Katarina Ejeskär · 2022 · Research Square
87. Characterisation of cancer stem cells and the renin-angiotensin system in colon adenocarcinoma
    Matthew J. Munro · 2021
88. Association between the Methylation of CpG Islands in JAK-STAT Pathway-Related Genes and Colorectal Cancer
    Rui Pu, Hongru Sun, Yupeng Liu, Tian Tian, Haoran Bi, Tingting Xia, Lei Zhang, Yuanyuan Zhang, Lin Zhu, Jiesheng Rong et al. · 2020 · Research Square
89. In Silico Inhibition of three Cancer Inducing Receptors, IL-6, CTLA-4, and B7-2 by Dostarlimab may explain the 100% Complete Recovery Rate in MMRd Locally Advanced Rectal Cancer seen in Pivotal ‘Immunoablative’ Neoadjuvant Immunotherapy Clinical Trial. A Cancer Therapy Breakthrough.
    Mahmoud Elkazzaz, Abdullah Haikal, Israa Mohamed Shamkh, Amr Kamel Khalil Ahmed · 2022 · Research Square
90. In Silico Inhibition of Three Cancer Inducing Receptors, IL-6, CTLA-4, and B7-2 by Dostarlimab may explain the 100% Complete Recovery Rate in MMRd Locally Advanced Rectal Cancer seen in Pivotal ‘Immunoablative’ Neoadjuvant Immunotherapy Clinical Trial. A Cancer Therapy Breakthrough.
    Mahmoud Elkazzaz, Abdullah Haikal, Israa Mohamed Shamkh, Amr Kamel Khalil Ahmed · 2022 · Research Square
91. Data from Epidermal Growth Factor Receptor Controls Flat Dysplastic Aberrant Crypt Foci Development and Colon Cancer Progression in the Rat Azoxymethane Model
    Urszula Dougherty, Amikar Sehdev, Sonia Cerda, Reba Mustafi, Nathaniel Little, Weihua Yuan, Sujatha Jagadeeswaran, Anusara Chumsangsri, Jorge Delgado, Maria Tretiakova et al. · 2023
92. Application of Nano-Antibodies for Cancer Immunotherapy
    Sunanda Singh, Samara P. Singh, Ashutosh S. Parihar · 2023 · Current Tissue Microenvironment Reports
93. The Characteristics Of Tumor Microenvironment In Colorectal Cancer With Different Msi Status And Current Therapeutic Strategies
    Qingzhe Wang, Min Yu, Shuang Zhang · 2023 · SSRN Electronic Journal
94. The Role of Cytokines in the Pathogenesis of Malignant Neoplasms
    Рыбкина Валентина Львовна, Galina V. Adamova, D. S. Oslina · 2023 · Cell and Tissue Biology
95. V.parvula regulates JAK2-STAT3 to promote colorectal cancer
    Xuhao Bai, jiaxin Deng, jiawei zhang, Qinghua Zhong, dezheng lin, jiancong hu, sen liao, juan li, bingfeng he, junhao wang et al. · 2024 · Research Square
96. Additional file 2 of Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids
    Mario Cioce, Maria Rita Fumagalli, Sara Donzelli, Frauke Goeman, Valeria Canu, Daniela Rutigliano, Giulia Orlandi, Andrea Sacconi, Claudio Pulito, Alina Catalina Palcau et al. · 2023 · Figshare
97. Tissue-specific atlas of trans-models for gene regulation elucidates complex regulation patterns
    Robert D. D’Agostino, Assaf Gottlieb · 2024 · BMC Genomics
98. Probabilistic graph-based model uncovers previously unseen druggable vulnerabilities in major solid cancers
    Ying Zhu, Stephanie Schmidt, Li Zhao, Chunjie Jiang, Patrizio Di Micco, Costas Mitsopoulos, P. Andrew Futreal, Bissan Al‐Lazikani · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
99. Splicing Factor 3a Subunit 1 Promotes Colorectal Cancer Growth via Anti-programmed cell death of Syntaxin12.
    Hiroaki Konishi, Takahiro Sasaki, Aki Sakatani, Hiroki Tanaka, Koji Yamamoto, Keitaro Takahashi, Katsuyoshi Ando, Nobuhiro Ueno, Shin Kashima, Kentaro Moriichi et al. · 2024 · Research Square
100. Silymarin induces multiple myeloma cell apoptosis by inhibiting the JAK2/STAT3 signaling pathway
     Haiyun Liu, Tingting Liu, Junquan Zeng, Quangang Fang · 2025 · Oncology Letters